Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index, and 1 are not checked yet.

Pulmonary Fibrosis

Chua, Felix, Gauldie, Jack, Laurent, Geoffrey J.·2005·American Journal of Respiratory Cell and Molecular Biology

Abstract

Substantial challenges remain in our understanding of fibrotic lung diseases. Nowhere is this more true than in the elucidation and verification of the pathogenetic basis upon which they develop. Scientific progress, most recently in the field of experimental therapy, has relied closely on interpreting data derived from animal modeling. Such models are used to identify the cellular interactions and molecular pathways involved in lung tissue repair and fibrosis. Over the coming years, the significance of new discoveries will continue to be evaluated using the in vivo analysis of animal models substituting for patients with actual pulmonary fibrosis. The commonest strategy to induce experimental pulmonary fibrosis is by directly administering a profibrotic agent to either wild-type animals or those that bear a specific genetic modification. The creation of new models has been greatly enhanced by the availability of stem cell lines and methods for introducing genetic mutations into these cells. Despite an increasing choice of models, there are still good reasons to continue adapting and using one of its earliest examples, the bleomycin model, in post-genomic pulmonary fibrosis research. A brief review of the exacting requirements of such research will place the strengths of this particular model in perspective.

Overview

Integrity signals

Registry

Crossref · 10.1165/rcmb.2005-0062tr

Cites

37 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 5

  1. 1993, Monogr Pathol, 36, 78
  2. 2002, Respir Res, 3, 1
  3. 1978, Am Rev Respir Dis, 117, 289
  4. 1996, Lab Invest, 74, 12
  5. 1993, Thorax, 48, 956

Cited by

See all 316

Metadata

Authors
Chua, F., Gauldie, J., & Laurent, G. J.
Affiliations
The Royal Free Hospital (GB)
Venue
American Journal of Respiratory Cell and Molecular Biology
Published
2005-07-01
Volume
33
Issue
1
Pages
9-13
ISSN
  • 1044-1549 (ISSN-L)
  • 1535-4989
OpenAlex
W2051772841
Cited by
305
References
36
Citations by year
2026: 2 · 2025: 9 · 2024: 10 · 2023: 24 · 2022: 18 · 2021: 7 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 12 · 2014: 19 · 2013: 19 · 2012: 12
FWCI
4.13
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
pulmonary fibrosis, bleomycin-induced fibrosis, experimental fibrosis, genetic modification, stem cell lines, lung repair, fibrosis pathogenesis, postgenomics
MeSH terms
Animals, Antimetabolites, Antineoplastic, Bleomycin, Disease Models, Animal, Extracellular Matrix, Fibrosis, Humans, Lung, Lung Diseases, Models, Biological, Mutation, Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1165/rcmb.2005-0062tr
The paper
Chua, F., Gauldie, J., & Laurent, G. J. (2005). Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2005-0062tr

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.